Pediatric drugs--a review of commercially available oral formulations.
about
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage formsSafe and effective pharmacotherapy in infants and preschool children: importance of formulation aspectsFormulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets.Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric useThe effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.The "child size medicines" concept: policy provisions in Uganda.Formulations for children: problems and solutionsDevelopment of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluationsAntiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.Oromucosal film preparations: points to consider for patient centricity and manufacturing processes.Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.Effects of yogurt and applesauce on the oral bioavailability of nilotinib in healthy volunteers.Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach.3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.Performing a preliminary hazard analysis applied to administration of injectable drugs to infants.The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation.A prospective study to assess the palatability of analgesic medicines in children.Beyond the pill: new medication delivery options for ADHD.Physicochemical and microbiological stability studies of extemporaneous antihypertensive pediatric suspensions for hospital use.Paediatric Over-the-Counter (OTC) Oral Liquids Can Soften and Erode Enamel.Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment.Organic-aqueous crossover coating process for the desmopressin orally disintegrating microparticles.Sweetener content and cariogenic potential of pediatric oral medications: A literature.
P2860
Q27027075-84C385C7-554C-460E-9C5D-30EB0DE962FCQ28079594-4B6CA91D-B692-4B26-A547-87E7FE18DD3EQ34447742-2BB7F901-FE47-43C9-9230-F1C257FD45BAQ34769107-E2500819-1D8C-4895-BC39-F0533A244AFEQ35078360-8EEE599B-E95C-4FD6-B6A0-89E2AE930FB9Q35125365-31A80B87-1275-4C71-A929-DBC4F4965A49Q35135943-AC82F1DD-8A4F-4327-9B58-00D5A5B62732Q35977237-04D48A4C-78A8-454B-A965-7621E8C71F0AQ37866289-EE38A2C1-FA2B-4874-8528-8D4E76E4DB4BQ37976848-4D319970-4A85-4BD1-8284-CD00DC702532Q38630904-62B9FE2E-948E-4F40-8E68-B60901481B67Q38819654-F772E478-EC4D-4EA9-B078-699A3909F8E6Q44189842-BE81AB32-6878-4D1E-AB3D-9E783ECE3D36Q45025025-DFC2FFCE-831C-4A69-B206-EBD605023F17Q47872103-97BF3726-BF13-48D5-A44E-712C44BD9982Q48170489-F71460A6-1737-4DE8-BB7F-F7750DF32412Q48192870-9BF469DD-D303-49C5-B883-4329819380E9Q49614185-E432B9FE-3608-497E-A3C2-F2BA039466C3Q50245908-65B05DAE-2562-45A4-9A18-003FCCDF5ABBQ50433156-796792DF-7420-4C6F-BACE-740EB7E75F28Q50939057-C97181B2-CF1A-49E6-9366-F7E35D943B32Q51732472-B407B4A9-F023-4EBE-9C6A-56359E318365Q53285942-C829ACDE-B516-4AC1-A653-FB196CE5A7F5Q53307774-2FD98200-49B0-402E-8556-E082D3433B8AQ55319046-8DEF45A7-7A25-4192-8559-18073B090EB6
P2860
Pediatric drugs--a review of commercially available oral formulations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Pediatric drugs--a review of commercially available oral formulations.
@en
type
label
Pediatric drugs--a review of commercially available oral formulations.
@en
prefLabel
Pediatric drugs--a review of commercially available oral formulations.
@en
P2093
P356
P1476
Pediatric drugs--a review of commercially available oral formulations.
@en
P2093
Quynh Iwata
Robert G Strickley
Terrence C Dahl
P304
P356
10.1002/JPS.21101
P407
P577
2008-05-01T00:00:00Z